Urol. praxi. 2017;18(5):206-208 | DOI: 10.36290/uro.2017.049

MRI targeted biopsy of the prostate – 2nd part: fusion techniques

MUDr. ©árka Kudláčková, doc. MUDr. Frantiąek Zá»ura, PhD.
Urologická klinika, Fakultní nemocnice Olomouc

Prostate carcinoma is one of few malignant tumors being difficult to be diagnosed by conventional imaging methods. On ultrasonographythat is normally used in the diagnosis of prostate cancer, typical hypoechogenic lesion is visible in only 30 %, whichresults in low TRUS sensitivity. In recent years,MRI and especially multi-parametric analysis appears to be promising solution. MRIvisualised lesion is biopted either in real-time using in-bore technique or by selected fusion technique.

Keywords: targeted biopsy of the prostate, MRI, fusion

Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kudláčková ©, Zá»ura F. MRI targeted biopsy of the prostate – 2nd part: fusion techniques. Urol. praxi. 2017;18(5):206-208. doi: 10.36290/uro.2017.049.
Download citation

References

  1. Kongnyuy M, George AK, Rastinehad AR, Pinto PA. Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: Review of technology, techniques, and outcomes. Curr Urol Rep 2016; 17: 32. Go to original source... Go to PubMed...
  2. Wegelin O, van Melick HHE, Hooft L, et al. Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 2017; 71: 517-531. Go to original source... Go to PubMed...
  3. Giannarini, Gianluca, et al. Multiparametric Magnetic Resonance Imaging Targeted Biopsy for Early Detection of Prostate Cancer: All That Glitters Is Not Gold! Eur Urol 2017; 71: 904-906. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.